InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.535
-0.045 (-1.74%)
Aug 12, 2025, 4:00 PM - Market closed
InspireMD Market Cap
InspireMD has a market cap or net worth of $105.14 million as of August 12, 2025. Its market cap has increased by 41.50% in one year.
Market Cap
105.14M
Enterprise Value
89.19M
1-Year Change
41.50%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $105.14M, an increase of 91.50%. That is a compound annual growth rate of 4.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 107.60M | 56.85% |
Dec 31, 2024 | 68.60M | 13.20% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
Apr 12, 2011 | 54.90M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 561.67B |
Johnson & Johnson | 417.44B |
AbbVie | 349.87B |
Abbott Laboratories | 233.71B |
AstraZeneca | 227.85B |
UnitedHealth Group | 227.59B |
Novartis AG | 225.61B |
Novo Nordisk | 224.34B |